Analytical Data
-
Gene name
RPL29
- Application
-
Alternative Names
Cell surface heparin-binding protein HIP (Large ribosomal subunit protein eL29)
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P47914
-
Expression Region
2-159aa
-
Molecular Weight
44.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL29, or ribosomal protein L29, is a crucial component of the ribosomal machinery, primarily involved in protein synthesis within the cell. Research on RPL29 has gained significance due to its potential roles in various biological processes, including cell growth, proliferation, and response to stress. Recent studies have highlighted its involvement in the regulation of gene expression and its implications in tumorigenesis and cancer progression. Given its essential function in ribosome assembly and stability, RPL29 has been implicated in the fine-tuning of translational control, making it a potential target for therapeutic interventions. Additionally, alterations in RPL29 expression levels have been associated with various diseases, underscoring its importance as a biomarker for cancer diagnosis and prognosis. The recombinant expression of RPL29 allows for in-depth functional studies, structural analysis, and the exploration of its interactions with other cellular components. Understanding the molecular mechanisms governing RPL29’s role in ribosomal function and cellular regulation could pave the way for novel strategies in cancer treatment and other pathologies linked to ribosomal dysfunction. Thus, ongoing research efforts are focused on elucidating RPL29’s multifaceted roles in biology, providing insights that may have significant implications for developing targeted therapeutic approaches.
